HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N Semeraro Selected Research
N Semeraro Research Topics
Disease
3
Thrombosis (Thrombus)
09/2008 - 04/2001
2
Colorectal Neoplasms (Colorectal Cancer)
02/2007 - 07/2003
2
Neoplasms (Cancer)
02/2007 - 07/2003
1
Hemorrhage
01/2016
1
Venous Thromboembolism
09/2008
1
Pulmonary Embolism
11/2005
1
Dyspepsia (Indigestion)
01/2005
1
Infections
01/2005
1
Neoplasm Metastasis (Metastasis)
07/2003
1
Chronic Granulomatous Disease
04/2001
1
Inflammation (Inflammations)
09/2000
Drug/Important Bio-Agent (IBA)
2
Fibrin
IBA
01/2016 - 09/2000
2
Antifibrinolytic Agents (Antifibrinolytics)
IBA
09/2008 - 01/2005
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2007 - 07/2003
2
Thromboplastin (Tissue Factor)
IBA
02/2007 - 07/2003
1
butyl phosphorotrithioate (DEF)
IBA
01/2016
1
Factor XI (Plasma Thromboplastin Antecedent)
IBA
01/2016
1
Anticoagulants
IBA
09/2008
1
Homocysteine
IBA
09/2008
1
Immunosorbents
IBA
02/2007
1
Enzymes
IBA
02/2007
1
Epinephrine (Adrenaline)
FDA Link
Generic
11/2005
1
1,2,6,7,8,8a- hexahydro- beta,delta,6- trihydroxy- 2- methyl- 8- (2- methyl- 1- oxobutoxy)- 1- naphthaleneheptanoic acid 4-(nitrooxy)butyl ester
IBA
11/2005
1
Collagen
IBA
11/2005
1
Proteins (Proteins, Gene)
FDA Link
01/2005
1
Prothrombin (Factor II)
IBA
01/2005
1
fibrin fragment D (D-dimer)
IBA
01/2005
1
Plasminogen Activator Inhibitor 1
IBA
01/2005
1
Plasminogen Activator Inhibitor 2
IBA
01/2005
1
Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)
IBA
01/2005
1
NADPH Oxidases (NAD(P)H oxidase)
IBA
04/2001
Therapy/Procedure
2
Therapeutics
09/2008 - 02/2007
1
Thrombolytic Therapy
04/2001